Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

482 projects found matching your search criteria :

  1. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer ...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Anna Kawiak

    Uniwersytet Gdański

  2. Regulation of ALKBH proteins expression in cancer and its role in cancer therapy.

    Call: OPUS 2 , Panel: NZ4

    Principal investigator: prof. Elżbieta Grzesiuk

    Instytut Biochemii i Biofizyki PAN

  3. Pathogenesis of ovarian cancer survival in non-adhesion conditions: transcriptomic assessment and studies of molecular t...

    Call: PRELUDIUM 2 , Panel: NZ1

    Principal investigator: dr Anna Stachurska

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

  4. Combined induction of cell death of canine leukemia and lymphoma.

    Call: OPUS 2 , Panel: NZ5

    Principal investigator: dr hab. Andrzej Marek Rapak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  5. MIST: Artificial intelligence-assisted design of experiments as a tool to streamline the development of siRNA-lipid nano...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Paulina Krystyna Skupin-Mrugalska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  6. The stabilization mechanism and dissolution kinetics of co-amorphous systems - a new perspective on enhancing the effica...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Agata Olszewska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  7. FHOD1 as a Regulator of Lipid Droplet–Mitochondria Interactions: A New Dimension of Metabolic Control in Skin Melanoma C...

    Call: OPUS 29 , Panel: NZ3

    Principal investigator: dr hab. Antonina Joanna Mazur

    Uniwersytet Wrocławski

  8. Phosphorylation-Dependent Regulation of IRS2 by DYRK1A: Implications for Diabetes Therapy

    Call: PRELUDIUM 24 , Panel: NZ1

    Principal investigator: Alicja Bis

    Uniwersytet Jagielloński

  9. Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinocice...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Michał Andrzej Abram

    Uniwersytet Jagielloński

  10. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  11. Development of Red-Emitting Chiral Carbon Dots for Advanced Photodynamic Therapy (PDT)

    Call: PRELUDIUM 24 , Panel: ST8

    Principal investigator: Patryk Szymaszek

    Politechnika Krakowska im. Tadeusza Kościuszki

  12. Activity evaluation of procaryotic TA modules in a dual-component model of cancer therapy

    Call: PRELUDIUM 2 , Panel: NZ5

    Principal investigator: Łukasz Janusz Wieteska

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu; Zakład Biochemii Medycznej

  13. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Robert Czarnomysy

    Uniwersytet Medyczny w Białymstoku

  14. The Impact of Endocannabinoid System Modulation and Enriched Environment on the Therapy of Myelination and Memory Disord...

    Call: PRELUDIUM 24 , Panel: NZ5

    Principal investigator: Justyna Anna Socha

    Uniwersytet Medyczny w Lublinie

  15. Synergistic enhancement of reactive oxygen species generation via combination of heavy atom effect with donor-acceptor a...

    Call: PRELUDIUM 24 , Panel: ST5

    Principal investigator: Karolina Anna Urbanowicz

    Politechnika Warszawska

  16. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  17. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

  18. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Natalia Anna Lehman

    Uniwersytet Medyczny w Lublinie

  19. Immersive virtual reality therapy combined with guided breathing exercises as a supportive intervention for reducing dep...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Magdalena Anna Nowak

    Politechnika Opolska

  20. Mini-tumors, big answers: Modeling of immune system's activation with organoid-based PDT-on-Chip technology

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Marta Karolina Warszyńska

    Uniwersytet Jagielloński

  21. Molecular Pathogenesis and Precision Antisense Oligonucleotide Therapy for BAG3-Related Myofibrillar Myopathy Type 6 Usi...

    Call: OPUS 29 , Panel: NZ2

    Principal investigator: dr Estera Elmira Rintz

    Uniwersytet Gdański

  22. Elimination of IgE-producing cells using next-generation chimeric antigen receptor (CAR)-based therapy

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Beata Kaleta

    Warszawski Uniwersytet Medyczny

  23. New approach to glioblastoma adoptive therapy based on inducible CAR expression system - SynCAR

    Call: OPUS 29 , Panel: NZ6

    Principal investigator: dr hab. Radosław Zagożdżon

    Warszawski Uniwersytet Medyczny

  24. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Katarzyna Aleksandra Szafrańska

    Uniwersytet Jagielloński

  25. Photoactive, supramolecular, and biocompatible materials suitable for antimicrobial photodynamic therapy

    Call: WEAVE-UNISONO , Panel: ST5

    Principal investigator: dr Dorota Anna Chełminiak-Dudkiewicz

    Uniwersytet Mikołaja Kopernika

  26. New violacein derivatives as candidates for sonodynamic therapy against skin cancer

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Daniel Ryszard Ziental

    Uniwersytet Przyrodniczy w Poznaniu

  27. Next-Generation Exosome Therapy: Engineering NK Cell-Derived Vesicles for Targeted Cancer Treatment

    Call: SONATINA 9 , Panel: NZ6

    Principal investigator: dr Daria Nawrocka

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  28. The role of DNA methylation in therapy that increases CFTR channel activity in cystic fibrosis

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Beata Maria Narożna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  29. The role of structural changes of lung surfactants in pulmonary diseases – from physicochemical description to effective...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: dr hab. Dorota Matyszewska

    Uniwersytet Warszawski

  30. Mind the gap! Plasmonic nanocavity for spectroscopic trapping of local molecularrearrangements in DNA upon epigenetic mo...

    Call: OPUS 28 , Panel: ST4

    Principal investigator: prof. Ewelina Wioletta Lipiec

    Uniwersytet Jagielloński

  31. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

  32. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk...

    Call: OPUS 28 , Panel: ST8

    Principal investigator: dr hab. Bożena Anna Tyliszczak

    Politechnika Krakowska im. Tadeusza Kościuszki

  33. The influence of beta2-receptor N-terminal polymorphismsadrenergic on its functionality, interactions withdrugs and the ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Anita Elżbieta Płazińska

    Uniwersytet Medyczny w Lublinie

  34. Prolonged-release of selected antiangiogenic proteins from innovative nanocarrier for use in adjuvant/additive multiple ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Bogusław Bronisław Machaliński

    Pomorski Uniwersytet Medyczny w Szczecinie

  35. Cannabidiol as a Neuroprotective Therapy: Are Brain Regeneration Mechanisms After Perinatal Hypoxia-Ischemia Sex-Depende...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Hanna Kletkiewicz

    Uniwersytet Mikołaja Kopernika

  36. Combating Hypoxia to prevent Right Ventricular Failure in experimental pulmonary hypertension - role of energetics, fibr...

    Call: OPUS 28 , Panel: NZ4

    Principal investigator: dr hab. Michał Maria Mączewski

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  37. Ir(III), Re(I) and Heterobimetallic Ir(III)–Re(I) Systems as Effective Emitters and Photosensitizers

    Call: SONATA 20 , Panel: ST4

    Principal investigator: dr Katarzyna Anna Choroba

    UNIWERSYTET ŚLĄSKI

  38. Investigation of the mechanism of enhanced liposome delivery to tumors and its application for dual target immunotherapy

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Piotr Rygiel

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  39. Environmental modulation of CDK4/6 inhibitor efficacy: Impact of mycotoxin alternariol exposure on anti-cancer therapies

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Anna Dominika Walczak-Szeffer

    Uniwersytet Medyczny w Łodzi

  40. Light Against Darkness: Biocompatible Photoactivated Pharmaceuticals for Combating Multidrug Resistant Bacterial Infecti...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński

  41. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr Martin Nurmik

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

  42. Biomimetic scaffolds modified with ferulic acid dedicated to necrotic wound therapy

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Beata Kaczmarek-Szczepańska

    Uniwersytet Mikołaja Kopernika

  43. Prevalence of viral genomes, histological, and immunohistochemical features of myocarditis in the myocardium, and freque...

    Call: SONATA 20 , Panel: NZ6

    Principal investigator: dr hab. Krzysztof Ozierański

    Warszawski Uniwersytet Medyczny

  44. Where Inhibition is not Enough- Development of Innovative Compounds for Targeted Degradation of Extracellular and Membra...

    Call: OPUS 28 (LAP) , Panel: NZ5

    Principal investigator: dr Marcin Skoreński

    Politechnika Wrocławska

  45. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  46. Application of bioconjugation strategy to the synthesis of anticancer Trojan horses

    Call: OPUS 28 , Panel: ST5

    Principal investigator: dr hab. Michał Piotr Antoszczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu

  47. Computational and experimental nanodosimetry for proton radiotherapy

    Call: WEAVE-UNISONO , Panel: ST2

    Principal investigator: dr hab. Antoni Wojciech Ruciński

    Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

  48. The first antibody-drug conjugates for Alzheimer's disease therapy

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr hab. Marcin Łukasz Poręba

    Politechnika Wrocławska

  49. Quad-TNT: Quadruplex-Targeted Photo-Therapy for Triple-Negative Tumors

    Call: SONATA BIS 14 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  50. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Call: OPUS 27 , Panel: NZ5

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy